Xie X - Search Results

1

miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.

Ye F, Tang H, Liu Q, Xie X, Wu M, Liu X, Chen B, Xie X. Ye F, et al. Among authors: xie x. J Transl Med. 2014 Jan 21;12:17. doi: 10.1186/1479-5876-12-17. J Transl Med. 2014. PMID: 24447584 Free PMC article.

2

Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.

Xie X, Guo J, Kong Y, Xie GX, Li L, Lv N, Xiao X, Tang J, Wang X, Liu P, Yang M, Xie Z, Wei W, Spencer DM, Xie X. Xie X, et al. Among authors: xie z, xie gx. J Gene Med. 2011 Dec;13(12):680-91. doi: 10.1002/jgm.1620. J Gene Med. 2011. PMID: 22009763

3

High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.

Kong Y, Dai S, Xie X, Xiao X, Lv N, Guo J, Li L, Jia W, Zhang Y, Liu W, Wei W, Xie X. Kong Y, et al. Among authors: xie x. J Cancer Res Clin Oncol. 2012 Feb;138(2):275-84. doi: 10.1007/s00432-011-1095-9. Epub 2011 Nov 25. J Cancer Res Clin Oncol. 2012. PMID: 22116318

4

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.

Lv N, Xie X, Ge Q, Lin S, Wang X, Kong Y, Shi H, Xie X, Wei W. Lv N, et al. Among authors: xie x. Diagn Pathol. 2011 Dec 2;6:118. doi: 10.1186/1746-1596-6-118. Diagn Pathol. 2011. PMID: 22132735 Free PMC article.

5

Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer.

Lv N, Lin S, Xie Z, Tang J, Ge Q, Wu M, Xie X, Xie X, Wei W. Lv N, et al. Among authors: xie x, xie z. Cancer Epidemiol. 2012 Aug;36(4):341-6. doi: 10.1016/j.canep.2012.01.004. Epub 2012 Mar 3. Cancer Epidemiol. 2012. PMID: 22386733

6

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.

Li L, Yuan L, Luo J, Gao J, Guo J, Xie X. Li L, et al. Among authors: xie x. Clin Exp Med. 2013 May;13(2):109-17. doi: 10.1007/s10238-012-0186-5. Epub 2012 May 24. Clin Exp Med. 2013. PMID: 22623155

7

Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.

Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, Kong Y, Lv N, Jia W, Zhang Y, Xie X. Wu M, et al. Among authors: xie x. Med Oncol. 2012 Dec;29(5):3240-9. doi: 10.1007/s12032-012-0260-6. Epub 2012 Jun 4. Med Oncol. 2012. PMID: 22661383

8

Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models.

Xie X, Li L, Xiao X, Guo J, Kong Y, Wu M, Liu W, Gao G, Hsu JL, Wei W, Hung MC, Xie X. Xie X, et al. Mol Cancer Ther. 2012 Sep;11(9):1915-24. doi: 10.1158/1535-7163.MCT-12-0191. Epub 2012 Jul 2. Mol Cancer Ther. 2012. PMID: 22752427

9

Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.

Li L, Xie X, Luo J, Liu M, Xi S, Guo J, Kong Y, Wu M, Gao J, Xie Z, Tang J, Wang X, Wei W, Yang M, Hung MC, Xie X. Li L, et al. Among authors: xie x, xie z. Mol Ther. 2012 Dec;20(12):2326-34. doi: 10.1038/mt.2012.201. Epub 2012 Oct 2. Mol Ther. 2012. PMID: 23032974 Free PMC article.

10

Clinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastases.

Ge QD, Lv N, Kong YN, Xie XH, He N, Xie XM, Wei WD. Ge QD, et al. Asian Pac J Cancer Prev. 2012;13(10):5081-6. doi: 10.7314/apjcp.2012.13.10.5081. Asian Pac J Cancer Prev. 2012. PMID: 23244114 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,450 results

Search Page

Filters